Eps Diluted - Cartesian Therapeutics Inc (NASDAQ:RNAC) - Alpha Spread

Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 16.54 USD 5.82% Market Closed
Market Cap: 353.6m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cartesian Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
EPS (Diluted)
-$13
CAGR 3-Years
-6%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$2
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-15%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$5
CAGR 3-Years
-17%
CAGR 5-Years
-15%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
-$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$37
CAGR 3-Years
-13%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Cartesian Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-13.1 USD

Based on the financial report for Jun 30, 2024, Cartesian Therapeutics Inc's EPS (Diluted) amounts to -13.1 USD.

What is Cartesian Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
20%

Over the last year, the EPS (Diluted) growth was -91%. The average annual EPS (Diluted) growth rates for Cartesian Therapeutics Inc have been -6% over the past three years , 20% over the past five years .

Back to Top